An integrated approach to the study of mitochondrial vitamin B12 pathway and type II fatty acid synthesis
线粒体维生素 B12 途径和 II 型脂肪酸合成研究的综合方法
基本信息
- 批准号:10343768
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesBindingBiochemical GeneticsBiochemistryBioinformaticsBiologyBranched-Chain Amino AcidsBrown FatCandidate Disease GeneCell physiologyCellsCellular biologyCitric Acid CycleClustered Regularly Interspaced Short Palindromic RepeatsCoenzyme AComputing MethodologiesCultured CellsCytosolDatabasesDevelopment PlansDiabetes MellitusDiagnosisDiet ModificationDiseaseDrug Metabolic DetoxicationEnvironmentEnzymatic BiochemistryEnzymesExhibitsFatty AcidsFundingGenesGenetic studyGoalsHealthHomeostasisHumanHuman GeneticsHuman GenomeInborn Errors of MetabolismInstitutesInterventionKnock-outLaboratoriesLesionLightLinkLipidsLyaseMalignant NeoplasmsMembrane LipidsMentorsMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMethionineMethodsMethylmalonyl-CoA MutaseMitochondriaMolecularMolecular DiagnosisMutationNational Research Service AwardsOctanoic AcidsOrphanOxidoreductasePathway interactionsPhasePhysiologicalPhysiologyProcessProteomeProteomicsRecyclingRegulationResearchResearch PersonnelResolutionRoleSequence HomologyTestingThioctic AcidTracerTrainingUnited States National Institutes of HealthVitamin B 12X-Ray Crystallographybasecareer developmentcofactorcomputerized toolsgenome editinggenome-widehuman diseasein vitro activityinhibitorinsightinterestlipidomicsloss of functionmetabolic abnormality assessmentmetabolomicsmethylmalonic aciduriamethylmalonyl-coenzyme Anovelprogramspropionyl-coenzyme Apublic databasestable isotopesuccinyl-coenzyme A
项目摘要
Abstract
The dysregulation of the metabolic pathways is the direct cause of inborn errors of metabolism and also
leads to common diseases like cancers and diabetes. The applicant's long-term objective is to develop
an integrated strategy combining computation, CRISPR genome editing and metabolomics to study the
poorly characterized metabolic pathways underlying human diseases. The results of these studies will
generate novel hypotheses for diagnosing metabolic diseases of unknown causes and provide
alternative directions for disease interventions. The applicant has previously obtained rigorous graduate
training in biochemistry and cell biology, including membrane lipid biology. During the ongoing NRSA
F32 postdoctoral funding period, the applicant has developed an integrated approach to study a
mitochondrial enzyme of unknown function, CLYBL, and revealed its function in regulating mitochondrial
vitamin B12 (B12)-dependent processes. This finding mirrors previous human genetic studies that
associate loss-of-function of CLYBL with low circulating B12 levels. For the K99/R00 application, the
applicant proposes to focus on two mitochondria-localized, essential metabolic pathways in human: (1) to
identify missing regulators of the mitochondrial B12 pathway; (2) to perform loss-of-function studies of
the mitochondrial type II fatty acid synthesis (mtFASII). To achieve these goals, two major strategies will
be applied: (a) to leverage genome-wide computational approaches and publicly available databases to
predict new pathway regulators; (b) to combine CRISPR editing in cultured cells and high-resolution LC-
MS based metabolomics (including lipidomics) and proteomics (including top-down proteomics) to probe
metabolism. The applicant's host laboratory and institute provide an ideal training environment for the
proposed research. Her postdoctoral mentor Dr. Vamsi Mootha's laboratory has previously developed
genome-wide computational methods to predict the mitochondrial proteome – the same toolset that
could predict novel metabolic regulators. The laboratory is also an early adopter of metabolomics and
part of the Broad Institute Metabolism Program. The applicant has obtained initial training in LC-MS
methods to profile polar metabolites. And during the K99/R00 funding period, she will receive additional
training in lipidomics and advanced native proteomics method to study the fatty acid acyl-chain extension
during the mtFASII. Successful completion of this project will provide fundamental insights into
mitochondrial cofactor metabolism and regulation of lipid homeostasis, and might introduce new
directions for diagnosing metabolic diseases. Meanwhile, the career development plan will prepare the
applicant to transition into an independent investigator in the field of metabolism.
抽象的
代谢途径的失调是代谢的先天错误的直接原因
导致癌症和糖尿病等常见疾病。申请人的长期目标是发展
结合计算,CRISPR基因组编辑和代谢组学的综合策略来研究
人类疾病潜在的代谢途径的特征不佳。这些研究的结果将
产生新的假设,用于未知原因的诊断代谢疾病,并提供
疾病干预措施的替代方向。适当的以前已经获得了严格的毕业生
包括膜脂质生物学在内的生物化学和细胞生物学培训。在正在进行的NRSA期间
F32博士后资金期间,适用的已开发了一种综合方法来研究
clybl的线粒体酶,并揭示其在确定线粒体方面的功能
维生素B12(B12)依赖性过程。这一发现反映了以前的人类遗传研究
CLYBL的功能丧失与低循环B12水平的功能丧失。对于K99/R00应用程序,
申请人的提议专注于人类中的两个线粒体定位的基本代谢途径:(1)至
确定线粒体B12途径的缺失调节剂; (2)进行功能丧失研究
线粒体II型脂肪酸合成(MTFASII)。为了实现这些目标,两种主要策略将
应用:(a)利用全基因组计算方法和公开可用的数据库
预测新的途径调节器; (b)在培养细胞和高分辨率LC-中结合CRISPR编辑
基于MS的代谢组学(包括脂质组学)和蛋白质组学(包括自上而下的蛋白质组学)以证明
代谢。申请人的房东实验室和研究所为
拟议的研究。她的博士后导师Vamsi Mootha博士以前已经开发了
全基因组的计算方法预测线粒体蛋白质组 - 与
可以预测新型的代谢调节剂。该实验室也是代谢组学的早期采用者
广泛研究所代谢计划的一部分。该应用程序已在LC-MS中获得了初步培训
剖析极地代谢产物的方法。在K99/R00的资金期间,她将获得额外
研究脂肪酸的培训和先进的天然蛋白质组学方法,以研究脂肪酸酰基链延伸
在mtfasii期间。成功完成该项目将提供基本的见解
线粒体辅因子代谢和脂质稳态调节,并可能引入新
诊断代谢疾病的方向。意思是,职业发展计划将准备
申请人过渡到代谢领域的独立研究者。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Systems biochemistry to "deorphanize" human mitochondrial proteome.
系统生物化学“去孤儿化”人类线粒体蛋白质组。
- DOI:10.1016/j.molcel.2022.07.005
- 发表时间:2022
- 期刊:
- 影响因子:16
- 作者:Miros,Francois;Liu,Ran;Shen,Hongying
- 通讯作者:Shen,Hongying
Combinatorial GxGxE CRISPR screen identifies SLC25A39 in mitochondrial glutathione transport linking iron homeostasis to OXPHOS.
- DOI:10.1038/s41467-022-30126-9
- 发表时间:2022-05-05
- 期刊:
- 影响因子:16.6
- 作者:Shi, Xiaojian;Reinstadler, Bryn;Shah, Hardik;To, Tsz-Leung;Byrne, Katie;Summer, Luanna;Calvo, Sarah E.;Goldberger, Olga;Doench, John G.;Mootha, Vamsi K.;Shen, Hongying
- 通讯作者:Shen, Hongying
An IRON-clad Connection between Aging Organelles.
衰老细胞器之间的铁一般连接。
- DOI:10.1016/j.cell.2019.12.037
- 发表时间:2020
- 期刊:
- 影响因子:64.5
- 作者:Shen,Hongying
- 通讯作者:Shen,Hongying
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongying Shen其他文献
Hongying Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongying Shen', 18)}}的其他基金
A systems approach to decode mitochondrial metabolite transport
解码线粒体代谢物运输的系统方法
- 批准号:
10713145 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
An integrated approach to the study of mitochondrial vitamin B12 pathway and type II fatty acid synthesis
线粒体维生素 B12 途径和 II 型脂肪酸合成研究的综合方法
- 批准号:
10087667 - 财政年份:2017
- 资助金额:
$ 24.9万 - 项目类别:
Functional characterization of a mitochondrial orphan enzyme
线粒体孤儿酶的功能表征
- 批准号:
9120683 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
结合态抗生素在水产品加工过程中的消解机制与产物毒性解析
- 批准号:32302247
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ABHD6与AMPA受体结合位点的鉴定及该位点在AMPA受体转运和功能调控中的作用研究
- 批准号:32300794
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-突触核蛋白与脂肪酸结合蛋白FABP3相互作用维持自身低聚体形态的机制研究
- 批准号:82301632
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于荧光共振能量转移机理构建多肽荧光探针用于可视化Zn2+结合SQSTM1/p62调节自噬在前列腺癌去势耐受中的作用机制
- 批准号:82303568
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
手性氢键供体与阴离子结合催化乙烯基醚的立体选择性阳离子聚合
- 批准号:22301279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Deciphering the lipid composition of primary cilia in human metabolic disease
破译人类代谢疾病中初级纤毛的脂质成分
- 批准号:
10696465 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Activation of C/EBP-β by mitohormesis as a therapy for obesity
通过线粒体毒物兴奋作用激活 C/EBP-β 作为肥胖疗法
- 批准号:
10369251 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Examining Molecular Regulation of Unconventional Cytoplasmic Protein Secretion
检查非常规细胞质蛋白分泌的分子调节
- 批准号:
10448325 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Examining Molecular Regulation of Unconventional Cytoplasmic Protein Secretion
检查非常规细胞质蛋白分泌的分子调节
- 批准号:
10188009 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别: